Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/22/1998US5851984 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
12/22/1998US5851806 Complementary adenoviral systems and cell lines
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851522 Enhancing keratinocyte migration
12/22/1998US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
12/22/1998CA2059363C Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same
12/22/1998CA1340281C Process for preparing and purifying alpha-interferon
12/20/1998CA2235441A1 Novel compounds
12/20/1998CA2235435A1 Novel compounds
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056925A1 Human protein phosphatase ii-c-like protein
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998WO1998056910A1 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE
12/17/1998WO1998056829A1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
12/17/1998WO1998056821A1 Alpha 1-antitrypsin preparation and method for the production thereof
12/17/1998WO1998056818A1 Human l105 proteins and polynucleotides encoding same
12/17/1998WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/17/1998WO1998056793A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same
12/17/1998WO1998056792A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same
12/17/1998WO1998056788A1 Imidazolyl-cyclic acetals
12/17/1998WO1998056786A1 2-aminoalkylaminoquinolines as dopamine d4 ligands
12/17/1998WO1998056771A2 Piperazine derivatives and their use as anti-inflammatory agents
12/17/1998WO1998056759A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998WO1998056426A1 Controlled release microencapsulated ngf formulation
12/17/1998WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998WO1998056404A1 Cns neuroregenerative compositions and methods of use
12/17/1998WO1998056401A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
12/17/1998WO1998056392A1 INHIBITORS OF β-LACTAMASES AND USES THEREFOR
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998WO1998056378A1 Novel niddm regimen
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056365A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
12/17/1998WO1998056355A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998040087A3 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
12/17/1998WO1998033919A3 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
12/17/1998WO1998023299A3 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
12/17/1998DE19826781A1 Pentaerythritol derivatives
12/17/1998DE19725391A1 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren A process for the production of medicaments comprising HMG-CoA reductase inhibitors
12/17/1998DE19724980A1 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use
12/17/1998DE19724979A1 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2295982A1 Human l105 proteins and polynucleotides encoding same
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2295013A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293825A1 Secreted proteins and polynucleotides encoding them
12/17/1998CA2293816A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same
12/17/1998CA2293666A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
12/17/1998CA2293492A1 Cns neuroregenerative compositions and methods of use
12/17/1998CA2293480A1 2-aminoalkylaminoquinolines as dopamine d4 ligands
12/17/1998CA2293440A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same
12/17/1998CA2293407A1 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998CA2293250A1 Human phosphatidylinositol transfer protein gamma
12/17/1998CA2293248A1 Human protein phosphatase ii-c-like protein
12/17/1998CA2292339A1 Smad6 and uses thereof
12/17/1998CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998CA2291055A1 Inhibitors of .beta.-lactamases and uses therefor
12/17/1998CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies
12/16/1998EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML)
12/16/1998EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884385A1 Intracellular modulators of apoptopic cell death pathways
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998EP0884310A1 Quinazolin-4-one ampa antagonists
12/16/1998EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses
12/16/1998EP0884052A1 Cartilage/bone inducing materials for reparation
12/16/1998EP0884050A1 Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes
12/16/1998EP0884049A1 Use of an alkylenedioxybenzene derivative for the treatment of circadian rythm sleep disorder
12/16/1998EP0883622A1 Proton pump inhibitor
12/16/1998EP0883616A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
12/16/1998EP0883606A1 Process for scavenging thiols
12/16/1998EP0883405A1 Amidino protease inhibitors
12/16/1998EP0883404A1 Combination therapy for osteoporosis
12/16/1998EP0883402A1 Novel cycloalkyl substituded imidazoles
12/16/1998EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998EP0883344A1 Therapeutic molecules generated by trans-splicing
12/16/1998EP0724572B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
12/16/1998EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998EP0592453B1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use
12/16/1998EP0532752B1 Compound tan-1251, its derivatives, their production and use
12/16/1998CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix
12/16/1998CN1202170A Quinoline derivatives as type 1V phosphodiesterase inhibitors
12/16/1998CN1202169A 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-HT4 or H3 receptor ligands
12/16/1998CN1202168A Quinolein-2(1H)-one derivatives as serotonin antagonists
12/16/1998CN1202164A Diarylalkenylamine derivatives
12/16/1998CN1202156A Cyclic and heterocyclic n-substituted 'alpha'-iminohydroxamic acid carboxylic acids
12/16/1998CN1202154A Aromatic carboxylic acid esters, production of same and use of same as medicaments
12/16/1998CN1202153A 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl) propyl carbamates and ureas and derivatives as neurokinin antagonists
12/16/1998CN1202114A Aqueous prolonged release formulation
12/16/1998CN1202107A Selective 'beta'3 adrenergic agonists
12/16/1998CN1202105A 2-alkylpyrrolidines
12/16/1998CN1202103A Excitatory amino acid receptor antagonists
12/16/1998CN1201791A Antiallergic agent having anti-oxidant action
12/16/1998CN1201684A Capsule of ginkgo and garlic extracts
12/16/1998CN1041204C Pentacyclic triterpenoid compound as toposomerase inhibitors or cell differentiation inducers
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 1564